The Food and Drug Administration Amendments Act of 2007 ('the Act' or 'FDAAA') will result in an unprecedented amount of information regarding the availability of approved products on the Internet. It remains to be seen whether the availability and accessibility of the information will increase a company's product liability exposure. To minimize their potential exposure, companies should prepare for the public vetting of information regarding their products, and develop appropriate approaches to address the Act's potential impact on product liability claims. This article discusses the Act and provides information for companies.